Literature DB >> 10536175

Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes.

T Fujita1, M Kiyama, Y Tomizawa, T Kohno, J Yokota.   

Abstract

To date, the characteristics of p53 gene mutations in lung cancer have been extensively investigated. However, current estimates of p53 alterations are inaccurate, since most investigators have limited their analyses to exons 5 to 8 of the p53 gene. We examined 52 lung carcinoma cell lines and 106 primary non-small cell lung carcinomas (NSCLC) for mutations in the entire coding region of the p53 gene, from exons 2 to 11. High resolution single strand conformation polymorphism analysis was performed using a modified electrophoretic apparatus with a high concentration gel (14%) and accurate temperature control. The prevalence of mutations was high (more than 80%) in both small cell lung carcinoma (SCLC) (15 of 18) and NSCLC cell lines (28 of 34), and 9 of 45 mutations (20%) were detected outside the region of exons 5 to 8. The frequency of the mutations in primary NSCLC was 48% (51 of 106) and was significantly different (p=0.01) between adenocarcinoma (39%) and squamous cell carcinoma (67%). A-->G transitions (14%, 6 of 43 cases) as well as G-->T transversions (26%, 11 of 43 cases) were frequently detected with significant strand bias in smoking patients, suggesting that carcinogens causing these mutations are involved in smoking associated lung carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10536175     DOI: 10.3892/ijo.15.5.927

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  18 in total

Review 1.  Macrocyclic inhibitors of hsp90.

Authors:  Victoria A Johnson; Erinprit K Singh; Lidia A Nazarova; Leslie D Alexander; Shelli R McAlpine
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

2.  Clinicopathological features and prognosis of small cell carcinoma of the cervix.

Authors:  Jie Liu; Yuan Li; Shuang Li; Dan Wang; Ting Hu; Yuhan Meng; Ding Ma; Hongbing Cai; Zehua Wang; Chengliang Xiong; Huiping Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

3.  Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines.

Authors:  Megumi Senju; Naoko Sueoka; Akemi Sato; Kentaro Iwanaga; Yukinori Sakao; Shinji Tomimitsu; Masaki Tominaga; Koji Irie; Shinichiro Hayashi; Eisaburo Sueoka
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-09       Impact factor: 4.553

4.  Prevalence and specificity of LKB1 genetic alterations in lung cancers.

Authors:  S Matsumoto; R Iwakawa; K Takahashi; T Kohno; Y Nakanishi; Y Matsuno; K Suzuki; M Nakamoto; E Shimizu; J D Minna; J Yokota
Journal:  Oncogene       Date:  2007-03-26       Impact factor: 9.867

5.  Malignant transformation of the mouse anorectal epithelium induced by an inoculated human cancer cell line.

Authors:  Hiroyuki Kuwano; Tatsuya Miyazaki; Soichi Tsutsumi; Minoru Fukuchi; Ken-Ichi Nomoto; Tatsuo Shimura; Erito Mochiki; Hiroyuki Kato; Takayuki Asao; Yasushi Toh
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

6.  Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.

Authors:  Nicolas Girard; Ronglai Shen; Tianhua Guo; Maureen F Zakowski; Adriana Heguy; Gregory J Riely; James Huang; Christopher Lau; Alex E Lash; Marc Ladanyi; Agnes Viale; Cristina R Antonescu; William D Travis; Valerie W Rusch; Mark G Kris; William Pao
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

7.  Metastatic small cell carcinoma to the thyroid gland: a pathologic and molecular study demonstrating the origin in the urinary bladder.

Authors:  Soraya Puente; Ana Velasco; Pilar Gallel; Judit Pallares; Luis Perez-Ruiz; Susana Ros; Javier Maravall; Xavier Matias-Guiu
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

8.  A gene-alteration profile of human lung cancer cell lines.

Authors:  Raquel Blanco; Reika Iwakawa; Moying Tang; Takashi Kohno; Barbara Angulo; Ruben Pio; Luis M Montuenga; John D Minna; Jun Yokota; Montse Sanchez-Cespedes
Journal:  Hum Mutat       Date:  2009-08       Impact factor: 4.878

9.  Stability and structural recovery of the tetramerization domain of p53-R337H mutant induced by a designed templating ligand.

Authors:  Susana Gordo; Vera Martos; Eva Santos; Margarita Menéndez; Carles Bo; Ernest Giralt; Javier de Mendoza
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-21       Impact factor: 11.205

10.  Unfolding, aggregation, and amyloid formation by the tetramerization domain from mutant p53 associated with lung cancer.

Authors:  Yuichiro Higashimoto; Yuya Asanomi; Satoru Takakusagi; Marc S Lewis; Kohei Uosaki; Stewart R Durell; Carl W Anderson; Ettore Appella; Kazuyasu Sakaguchi
Journal:  Biochemistry       Date:  2006-02-14       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.